APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhaled NO Vasodilator

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Inhaled NO Vasodilator Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026174 pages

Choose your research edition.

Industry ResearchInhaled NO Vasodilator Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhaled NO Vasodilator Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Inhaled NO Vasodilator Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhaled NO Vasodilator Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhaled NO Vasodilator Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Inhaled NO Vasodilator market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Inhaled NO Vasodilator is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inhaled NO Vasodilator is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhaled NO Vasodilator is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Inhaled NO Vasodilator is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Inhaled NO Vasodilator include Air Liquide, BOC Healthcare (Linde Group), Mallinckrodt and Praxair (Linde plc), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Inhaled NO Vasodilator market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhaled NO Vasodilator and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhaled NO Vasodilator sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inhaled NO Vasodilator market size, projected growth trends, production technologies, key applications, and end-use industries.

Inhaled NO Vasodilator Segment by Company

Air Liquide

BOC Healthcare (Linde Group)

Mallinckrodt

Praxair (Linde plc)

Inhaled NO Vasodilator Segment by Type

800 ppm

100 ppm

Others

Inhaled NO Vasodilator Segment by Application

PPHN

ARDS

Others

Inhaled NO Vasodilator Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaled NO Vasodilator market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhaled NO Vasodilator and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaled NO Vasodilator.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inhaled NO Vasodilator market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inhaled NO Vasodilator manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Inhaled NO Vasodilator in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Inhaled NO Vasodilator in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Inhaled NO Vasodilator Industry Trends Table 2. Inhaled NO Vasodilator Industry Drivers Table 3. Inhaled NO Vasodilator Industry Opportunities and Challenges Table 4. Inhaled NO Vasodilator Industry Restraints Table 5. Global Inhaled NO Vasodilator Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Inhaled NO Vasodilator Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Inhaled NO Vasodilator Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Inhaled NO Vasodilator Sales Market Share by Manufacturers Table 9. Global Inhaled NO Vasodilator Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Inhaled NO Vasodilator Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Inhaled NO Vasodilator Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Inhaled NO Vasodilator Manufacturers, Product Type & Application Table 13. Global Inhaled NO Vasodilator Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Inhaled NO Vasodilator by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 800 ppm Table 17. Major Manufacturers of 100 ppm Table 18. Major Manufacturers of Others Table 19. Global Inhaled NO Vasodilator Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Inhaled NO Vasodilator Sales by Type (2021-2026) & (K Units) Table 21. Global Inhaled NO Vasodilator Sales by Type (2027-2032) & (K Units) Table 22. Global Inhaled NO Vasodilator Sales Market Share by Type (2021-2026) Table 23. Global Inhaled NO Vasodilator Sales Market Share by Type (2027-2032) Table 24. Global Inhaled NO Vasodilator Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Inhaled NO Vasodilator Revenue by Type (2021-2026) & (K Units) Table 26. Global Inhaled NO Vasodilator Revenue by Type (2027-2032) & (K Units) Table 27. Global Inhaled NO Vasodilator Revenue Market Share by Type (2021-2026) Table 28. Global Inhaled NO Vasodilator Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of PPHN Table 30. Major Manufacturers of ARDS Table 31. Major Manufacturers of Others Table 32. Global Inhaled NO Vasodilator Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Inhaled NO Vasodilator Sales by Application (2021-2026) & (K Units) Table 34. Global Inhaled NO Vasodilator Sales by Application (2027-2032) & (K Units) Table 35. Global Inhaled NO Vasodilator Sales Market Share by Application (2021-2026) Table 36. Global Inhaled NO Vasodilator Sales Market Share by Application (2027-2032) Table 37. Global Inhaled NO Vasodilator Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Inhaled NO Vasodilator Revenue by Application (2021-2026) & (K Units) Table 39. Global Inhaled NO Vasodilator Revenue by Application (2027-2032) & (K Units) Table 40. Global Inhaled NO Vasodilator Revenue Market Share by Application (2021-2026) Table 41. Global Inhaled NO Vasodilator Revenue Market Share by Application (2027-2032) Table 42. Global Inhaled NO Vasodilator Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Inhaled NO Vasodilator Sales by Region (2021-2026) & (K Units) Table 44. Global Inhaled NO Vasodilator Sales Market Share by Region (2021-2026) Table 45. Global Inhaled NO Vasodilator Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Inhaled NO Vasodilator Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Inhaled NO Vasodilator Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Inhaled NO Vasodilator Sales by Country (2021-2026) & (K Units) Table 49. North America Inhaled NO Vasodilator Sales by Country (2027-2032) & (K Units) Table 50. Europe Inhaled NO Vasodilator Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Inhaled NO Vasodilator Sales by Country (2021-2026) & (K Units) Table 52. Europe Inhaled NO Vasodilator Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Inhaled NO Vasodilator Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Inhaled NO Vasodilator Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Inhaled NO Vasodilator Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Inhaled NO Vasodilator Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Inhaled NO Vasodilator Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Inhaled NO Vasodilator Sales by Country (2027-2032) & (K Units) Table 59. Global Inhaled NO Vasodilator Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Inhaled NO Vasodilator Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Inhaled NO Vasodilator Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Inhaled NO Vasodilator Revenue Market Share by Region (2021-2026) Table 63. Global Inhaled NO Vasodilator Revenue Market Share by Region (2027-2032) Table 64. Air Liquide Company Information Table 65. Air Liquide Business Overview Table 66. Air Liquide Inhaled NO Vasodilator Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Air Liquide Inhaled NO Vasodilator Product Portfolio Table 68. Air Liquide Recent Development Table 69. BOC Healthcare (Linde Group) Company Information Table 70. BOC Healthcare (Linde Group) Business Overview Table 71. BOC Healthcare (Linde Group) Inhaled NO Vasodilator Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. BOC Healthcare (Linde Group) Inhaled NO Vasodilator Product Portfolio Table 73. BOC Healthcare (Linde Group) Recent Development Table 74. Mallinckrodt Company Information Table 75. Mallinckrodt Business Overview Table 76. Mallinckrodt Inhaled NO Vasodilator Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Mallinckrodt Inhaled NO Vasodilator Product Portfolio Table 78. Mallinckrodt Recent Development Table 79. Praxair (Linde plc) Company Information Table 80. Praxair (Linde plc) Business Overview Table 81. Praxair (Linde plc) Inhaled NO Vasodilator Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Praxair (Linde plc) Inhaled NO Vasodilator Product Portfolio Table 83. Praxair (Linde plc) Recent Development Table 84. Key Raw Materials Table 85. Raw Materials Key Suppliers Table 86. Inhaled NO Vasodilator Distributors List Table 87. Inhaled NO Vasodilator Customers List Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources Table 91. Primary Sources List of Figures Figure 1. Inhaled NO Vasodilator Product Image Figure 2. Global Inhaled NO Vasodilator Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhaled NO Vasodilator Market Size (2021-2032) & (US$ Million) Figure 4. Global Inhaled NO Vasodilator Sales (2021-2032) & (K Units) Figure 5. Global Inhaled NO Vasodilator Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Inhaled NO Vasodilator Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 800 ppm Image Figure 9. 100 ppm Image Figure 10. Others Image Figure 11. Global Inhaled NO Vasodilator Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Inhaled NO Vasodilator Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Inhaled NO Vasodilator Sales Market Share by Type (2021-2032) Figure 14. Global Inhaled NO Vasodilator Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Inhaled NO Vasodilator Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Inhaled NO Vasodilator Revenue Market Share by Type (2021-2032) Figure 17. PPHN Image Figure 18. ARDS Image Figure 19. Others Image Figure 20. Global Inhaled NO Vasodilator Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Inhaled NO Vasodilator Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Inhaled NO Vasodilator Sales Market Share by Application (2021-2032) Figure 23. Global Inhaled NO Vasodilator Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Inhaled NO Vasodilator Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Inhaled NO Vasodilator Revenue Market Share by Application (2021-2032) Figure 26. North America Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Inhaled NO Vasodilator Sales Market Share by Country (2021-2032) Figure 28. U.S. Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Inhaled NO Vasodilator Sales Market Share by Country (2021-2032) Figure 33. Germany Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Inhaled NO Vasodilator Sales Market Share by Country (2021-2032) Figure 40. China Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Inhaled NO Vasodilator Sales Market Share by Country (2021-2032) Figure 48. Brazil Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Inhaled NO Vasodilator Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Inhaled NO Vasodilator Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Inhaled NO Vasodilator Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Figure 59. North America Inhaled NO Vasodilator Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Figure 61. Europe Inhaled NO Vasodilator Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Inhaled NO Vasodilator Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Inhaled NO Vasodilator Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Inhaled NO Vasodilator Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Inhaled NO Vasodilator Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Inhaled NO Vasodilator Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 800 ppm
  • 100 ppm
  • Others
Applications
  • PPHN
  • ARDS
  • Others
Companies covered
  • Air Liquide
  • BOC Healthcare (Linde Group)
  • Mallinckrodt
  • Praxair (Linde plc)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Inhaled NO Vasodilator Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Inhaled NO Vasodilator Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Inhaled NO Vasodilator Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Inhaled NO Vasodilator Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Inhaled NO Vasodilator Market Dynamics
  1. 2.1 Inhaled NO Vasodilator Industry Trends
  2. 2.2 Inhaled NO Vasodilator Industry Drivers
  3. 2.3 Inhaled NO Vasodilator Industry Opportunities and Challenges
  4. 2.4 Inhaled NO Vasodilator Industry Restraints
3 Inhaled NO Vasodilator Market by Manufacturers
  1. 3.1 Global Inhaled NO Vasodilator Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Inhaled NO Vasodilator Sales by Manufacturers (2021-2026)
  3. 3.3 Global Inhaled NO Vasodilator Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Inhaled NO Vasodilator Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inhaled NO Vasodilator Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Inhaled NO Vasodilator Manufacturers, Product Type & Application
  7. 3.7 Global Inhaled NO Vasodilator Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inhaled NO Vasodilator Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inhaled NO Vasodilator Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inhaled NO Vasodilator Tier 1, Tier 2, and Tier 3
4 Inhaled NO Vasodilator Market by Type
  1. 4.1 Inhaled NO Vasodilator Type Introduction
  2. 4.1.1 800 ppm
  3. 4.1.2 100 ppm
  4. 4.1.3 Others
  5. 4.2 Global Inhaled NO Vasodilator Sales by Type
  6. 4.2.1 Global Inhaled NO Vasodilator Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Inhaled NO Vasodilator Sales by Type (2021-2032)
  8. 4.2.3 Global Inhaled NO Vasodilator Sales Market Share by Type (2021-2032)
  9. 4.3 Global Inhaled NO Vasodilator Revenue by Type
  10. 4.3.1 Global Inhaled NO Vasodilator Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Inhaled NO Vasodilator Revenue by Type (2021-2032)
  12. 4.3.3 Global Inhaled NO Vasodilator Revenue Market Share by Type (2021-2032)
5 Inhaled NO Vasodilator Market by Application
  1. 5.1 Inhaled NO Vasodilator Application Introduction
  2. 5.1.1 PPHN
  3. 5.1.2 ARDS
  4. 5.1.3 Others
  5. 5.2 Global Inhaled NO Vasodilator Sales by Application
  6. 5.2.1 Global Inhaled NO Vasodilator Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Inhaled NO Vasodilator Sales by Application (2021-2032)
  8. 5.2.3 Global Inhaled NO Vasodilator Sales Market Share by Application (2021-2032)
  9. 5.3 Global Inhaled NO Vasodilator Revenue by Application
  10. 5.3.1 Global Inhaled NO Vasodilator Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Inhaled NO Vasodilator Revenue by Application (2021-2032)
  12. 5.3.3 Global Inhaled NO Vasodilator Revenue Market Share by Application (2021-2032)
6 Global Inhaled NO Vasodilator Sales by Region
  1. 6.1 Global Inhaled NO Vasodilator Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inhaled NO Vasodilator Sales by Region (2021-2032)
  3. 6.2.1 Global Inhaled NO Vasodilator Sales by Region (2021-2026)
  4. 6.2.2 Global Inhaled NO Vasodilator Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Inhaled NO Vasodilator Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Inhaled NO Vasodilator Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Inhaled NO Vasodilator Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Inhaled NO Vasodilator Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Inhaled NO Vasodilator Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Inhaled NO Vasodilator Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Inhaled NO Vasodilator Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Inhaled NO Vasodilator Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Inhaled NO Vasodilator Revenue by Region
  1. 7.1 Global Inhaled NO Vasodilator Revenue by Region
  2. 7.1.1 Global Inhaled NO Vasodilator Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Inhaled NO Vasodilator Revenue by Region (2021-2026)
  4. 7.1.3 Global Inhaled NO Vasodilator Revenue by Region (2027-2032)
  5. 7.1.4 Global Inhaled NO Vasodilator Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Inhaled NO Vasodilator Revenue (2021-2032)
  8. 7.2.2 North America Inhaled NO Vasodilator Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Inhaled NO Vasodilator Revenue (2021-2032)
  11. 7.3.2 Europe Inhaled NO Vasodilator Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Inhaled NO Vasodilator Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Inhaled NO Vasodilator Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Inhaled NO Vasodilator Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Inhaled NO Vasodilator Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Air Liquide
  2. 8.1.1 Air Liquide Company Information
  3. 8.1.2 Air Liquide Business Overview
  4. 8.1.3 Air Liquide Inhaled NO Vasodilator Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Air Liquide Inhaled NO Vasodilator Product Portfolio
  6. 8.1.5 Air Liquide Recent Developments
  7. 8.2 BOC Healthcare (Linde Group)
  8. 8.2.1 BOC Healthcare (Linde Group) Company Information
  9. 8.2.2 BOC Healthcare (Linde Group) Business Overview
  10. 8.2.3 BOC Healthcare (Linde Group) Inhaled NO Vasodilator Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BOC Healthcare (Linde Group) Inhaled NO Vasodilator Product Portfolio
  12. 8.2.5 BOC Healthcare (Linde Group) Recent Developments
  13. 8.3 Mallinckrodt
  14. 8.3.1 Mallinckrodt Company Information
  15. 8.3.2 Mallinckrodt Business Overview
  16. 8.3.3 Mallinckrodt Inhaled NO Vasodilator Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mallinckrodt Inhaled NO Vasodilator Product Portfolio
  18. 8.3.5 Mallinckrodt Recent Developments
  19. 8.4 Praxair (Linde plc)
  20. 8.4.1 Praxair (Linde plc) Company Information
  21. 8.4.2 Praxair (Linde plc) Business Overview
  22. 8.4.3 Praxair (Linde plc) Inhaled NO Vasodilator Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Praxair (Linde plc) Inhaled NO Vasodilator Product Portfolio
  24. 8.4.5 Praxair (Linde plc) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inhaled NO Vasodilator Value Chain Analysis
  2. 9.1.1 Inhaled NO Vasodilator Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inhaled NO Vasodilator Production Mode & Process
  6. 9.2 Inhaled NO Vasodilator Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inhaled NO Vasodilator Distributors
  9. 9.2.3 Inhaled NO Vasodilator Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst